What is PSA?
“PSA, or prostate specific antigen, is an enzyme that normally appears in the ejaculate or central reproduction but when there’s a cancer present, it leaks… Read More »What is PSA?
prostate cancer
Why do recommendations for colon cancer and prostate cancer screening tend to start around age 50?
“If you look at the overall incidence of cancer in the U.S., 80% of all cancers are diagnosed in people older than 60, and 30% of… Read More »Why do recommendations for colon cancer and prostate cancer screening tend to start around age 50?
Is there any test for prostate cancer that doesn’t depend on a blood test for PSA?
“There are an increasing collection of tests that sample other aspects of prostate cancer in urine, blood or tissue, including acquired gene defects in the… Read More »Is there any test for prostate cancer that doesn’t depend on a blood test for PSA?
What you need to know about prostate cancer screening guidelines
Prostate-specific antigen (PSA)-based screening for prostate cancer has received mixed reviews from different organizations, says William G. Nelson, M.D., Ph.D., director of the Johns Hopkins… Read More »What you need to know about prostate cancer screening guidelines
ASCO’s Best of 2014
What better way to begin 2015 than with a nod to our scientists who, according to the American Society of Clinical Oncology (ASCO), have led… Read More »ASCO’s Best of 2014
Hormone Therapy Combined with Chemotherapy Increases Survival for Prostate Cancer Patients
Early results from a study funded by the National Institutes of Health (NIH) have shown that men with hormone-sensitive metastatic prostate cancer who have received… Read More »Hormone Therapy Combined with Chemotherapy Increases Survival for Prostate Cancer Patients
Cancer News Review
Prostate cancer topics abound in the latest Cancer News Review podcast. Dr. Bill Nelson, director of the Johns Hopkins Kimmel Cancer Center, discusses Hopkins-led research, published in… Read More »Cancer News Review
Top Trends in Cancer Research 2011
It's been a game-changing year in cancer research. Doctors and scientists don't typically like to use those words, but here's why I think this is a… Read More »Top Trends in Cancer Research 2011
Cancer Screening Tests Everyone Should Know
Kimmel Cancer experts frequently say that “the best way to cure cancer is to prevent it from ever occurring.” Most experts agree that currently-available cancer… Read More »Cancer Screening Tests Everyone Should Know
Cancer News Review: Top Stories
Three stories top the list of major developments in cancer research during the past month. Listen to these topics discussed in the most recent Cancer News Review podcast.
First, to treat or not to treat is the question for low-risk prostate cancer. Whether to give aggressive treatments for low-risk cancer contained within the prostate is a controversy that many experts in the field still debate. Prostate cancer expert and Kimmel Cancer Center director William Nelson reviews a study analyzing how treatment decisions for these cancers are made and how quality of life expectations are communicated. He says the current problem is that screening, which has helped decrease mortality from prostate cancer, has identified some men who could live their entire lives with prostate cancer but die of other causes. He believes there are certain groups of men who should consider active surveillance programs to carefully monitor low-risk, organ-confined prostate cancer.
- « Previous
- 1
- 2
- 3
- 4
- Next »